Published in Cochrane Database Syst Rev on January 25, 2005
Subarachnoid haemorrhage. BMJ (2006) 1.74
Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care (2007) 1.42
Determinants of human cerebral pressure-flow velocity relationships: new insights from vascular modelling and Ca²⁺ channel blockade. J Physiol (2011) 1.42
Axonal damage and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2006) 1.08
Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage. Arch Neurol (2010) 1.03
Intraarterial nimodipine infusion to treat symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc (2009) 0.88
Reversible cerebral angiopathy: efficacy of nimodipine. J Neurol (2006) 0.85
Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding. Acta Neurochir (Wien) (2009) 0.82
Impact of heme and heme degradation products on vascular diameter in mouse visual cortex. J Am Heart Assoc (2014) 0.76
Prevention of delayed cerebral ischaemia after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2006) 0.75
Impact of Comorbidity on Early Outcome of Patients with Subarachnoid Hemorrhage Caused by Cerebral Aneurysm Rupture. Med Arch (2015) 0.75
Early-phase pharmacokinetics of enteral and parenteral nimodipine in patients with acute subarachnoid haemorrhage - a pilot study. Eur J Clin Pharmacol (2007) 0.75
Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1988) 20.14
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2001) 5.18
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13
Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12
Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke (2001) 3.90
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 3.67
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
[Fever, large eyes and confusion; the anticholinergic syndrome]. Ned Tijdschr Geneeskd (2002) 3.30
Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry (2007) 3.17
High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology (1990) 3.05
[Those who cannot remember the past are condemned to repeat it]. Ned Tijdschr Geneeskd (2006) 2.98
Intracerebral hematomas during anticoagulant treatment. Stroke (1990) 2.97
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69
Injection with methylprednisolone proximal to the carpal tunnel: randomised double blind trial. BMJ (1999) 2.57
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke (1999) 2.49
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology (1998) 2.39
Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder. Brain (2006) 2.35
Association of intraoperative transcranial doppler monitoring variables with stroke from carotid endarterectomy. Stroke (2000) 2.33
Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31
Circle of Willis: morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology (1998) 2.30
Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet (1991) 2.30
The diagnosis of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 2.29
Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet (2001) 2.29
Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology (1985) 2.18
Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry (1990) 2.15
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14
Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation (1995) 2.13
Carotid endarterectomy with transcranial Doppler and electroencephalographic monitoring. A prospective study in 130 operations. Stroke (1993) 2.13
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
The time course of aneurysmal haemorrhage on computed tomograms. Neuroradiology (1982) 2.06
Ticlopidine, trials, and torture. Stroke (1994) 2.04
[There is no such thing as the CVA]. Ned Tijdschr Geneeskd (1991) 2.03
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? J Neurol Neurosurg Psychiatry (1999) 2.03
[Functional imaging of the brain in the investigation of chronic unexplained pain]. Ned Tijdschr Geneeskd (2007) 2.02
[Measuring the functional status of patients in clinical trials using modern clinimetric methods]. Ned Tijdschr Geneeskd (2002) 2.01
Xanthochromia after subarachnoid haemorrhage needs no revisitation. J Neurol Neurosurg Psychiatry (1989) 1.95
Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline. J Neurol Neurosurg Psychiatry (2001) 1.92
Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke (1997) 1.92
The clinical course of perimesencephalic nonaneurysmal subarachnoid hemorrhage. Ann Neurol (1991) 1.89
Warning headache in aneurysmal subarachnoid hemorrhage. A case-control study. Arch Neurol (1988) 1.89
Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg (1985) 1.87
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry (1996) 1.87
Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain (2005) 1.85
Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke (1990) 1.83
Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke (1998) 1.82
Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80
Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. BMJ (1988) 1.76
Long-term follow-up of 71 patients with thunderclap headache mimicking subarachnoid haemorrhage. Lancet (1988) 1.73
Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 1.73
Spinal infarction. A follow-up study. Stroke (1993) 1.72
[On the way to our 200th anniversary]. Ned Tijdschr Geneeskd (2007) 1.72
Apnoea testing to confirm brain death in clinical practice. J Neurol Neurosurg Psychiatry (1986) 1.72
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
[Diagnostic image (156). A man with a hematoma behind the ear. Mastoid bone fracture]. Ned Tijdschr Geneeskd (2003) 1.69
Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation (1999) 1.69
[Creative mathematics with clopidogrel; exaggeration of the preventive effect by manufacturer]. Ned Tijdschr Geneeskd (1999) 1.68
Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Lancet (1992) 1.68
First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophr Res (2010) 1.68
Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry (1993) 1.67
A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol (1999) 1.67
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci (1985) 1.67
Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology (2007) 1.64
Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ (1995) 1.62
Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan? J Neurol Neurosurg Psychiatry (1995) 1.61
Outcome in familial subarachnoid hemorrhage. Stroke (1995) 1.59